Russia Approves Oncophage For Kidney Cancer Treatment

Armen Hareyan's picture

Antigenics Inc. (NASDAQ: AGEN) today announced that the Russian Ministry of Public Health has issued a registration certificate for the use of Oncophage

Share this content.

If you liked this article and think it may help your friends, consider sharing or tweeting it to your followers.